$cat ./funds/brandon-capital.md
Brandon Capital
Melbourne · est. 2007 · A$800M AUM
Brandon Capital is the largest specialist life sciences investor in Australia and New Zealand, manager of the Medical Research Commercialisation Fund (MRCF).
Website
Stages
Seed, Series A, Series B, Series C
Fund size
A$800M
Partners
Stephen Thompson, Chris Nave, David Fisher
Founded
2007
HQ
Melbourne
$ls ./funds/brandon-capital/portfolio
Notable investments
- — Vaxxas
- — Fibrotech
- — Hatchtech
- — Spinifex Pharmaceuticals
- — Cynata Therapeutics
$git log --reverse --pretty=short ./funds/brandon-capital.md
Timeline
verified · public sources- 2007Brandon Capital founded in Melbourne.verified · brandoncapital.com.au
- Mar 2023Closes BioMedical Translation Bridge fund at A$100M with federal co-funding.verified · Brandon
- Oct 2024Vaxxas advances Phase II trials of needle-free vaccine patch with US partners.verified · Capital Brief